Vivus says obesity drug may fail EU test, shares fall

(Reuters) - Vivus Inc said its obesity drug, the first diet pill launched in the United States in over a decade, is unlikely to be recommended by a European regulatory committee, sending its shares down 14 percent. Safety issues associated with earlier obesity drugs, such as the notorious "fen-phen" diet-drug combo, led to health regulators being cautious with approving such pills. ...

Source: http://news.yahoo.com/vivus-obesity-drug-may-not-eu-committee-backing-112822131--finance.html

DJ Drama T. Mills Jack White Electric Guest